Argyle Capital Management Inc. - Q3 2023 holdings

$273 Million is the total value of Argyle Capital Management Inc.'s 122 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .

 Value Shares↓ Weighting
AMGN BuyAmgen Inc$6,919,495
+24.7%
25,746
+3.0%
2.54%
+26.8%
JPM BuyJP Morgan Chase & Co$6,210,772
+3.3%
42,827
+3.6%
2.28%
+5.0%
CVX BuyChevron Corporation$5,230,930
+11.8%
31,022
+4.4%
1.92%
+13.6%
RTX BuyRTX Corporation$4,300,351
-21.1%
59,752
+7.4%
1.58%
-19.8%
PNC BuyPNC Finl Svcs Group Inc$4,271,537
+2.1%
34,793
+4.8%
1.56%
+3.8%
INTC BuyIntel Corp$4,232,334
+14.6%
119,053
+7.8%
1.55%
+16.5%
BMY BuyBristol Myers Squibb Co$4,223,482
-3.2%
72,768
+6.6%
1.55%
-1.7%
IBM BuyInternational Business Mach$3,922,367
+5.2%
27,957
+0.3%
1.44%
+6.8%
MDT BuyMedtronic Inc$3,711,913
-8.1%
47,370
+3.3%
1.36%
-6.7%
DUK BuyDuke Energy Corp$3,661,996
+3.3%
41,491
+5.1%
1.34%
+5.0%
BAC BuyBank of America Corp$3,597,540
+9.1%
131,393
+14.4%
1.32%
+10.9%
DOW BuyDow Inc$3,286,177
+2.3%
63,735
+5.6%
1.20%
+4.0%
ENB BuyEnbridge Inc$3,253,251
-5.7%
98,019
+5.5%
1.19%
-4.2%
CVS BuyCVS Health Corp$3,093,794
+8.3%
44,311
+7.3%
1.13%
+10.1%
VZ BuyVerizon Communications$3,041,776
-8.3%
93,853
+5.2%
1.11%
-6.9%
FISV BuyFiserv Inc$2,807,734
-6.7%
24,856
+4.2%
1.03%
-5.3%
T BuyAT&T Inc$2,799,810
+7.6%
186,405
+14.3%
1.03%
+9.4%
ALL BuyAllstate Corp$2,662,142
+8.5%
23,895
+6.2%
0.98%
+10.3%
MMM Buy3M Co$2,174,886
+2.3%
23,231
+9.4%
0.80%
+4.0%
BAX BuyBaxter Intl Inc$2,106,986
-11.8%
55,829
+6.4%
0.77%
-10.4%
CTVA BuyCorteva Inc$1,781,135
-4.6%
34,815
+6.8%
0.65%
-3.1%
F BuyFord Mtr Co Del$1,730,938
-16.5%
139,367
+1.7%
0.63%
-15.2%
TFC BuyTruist Finl Corp$1,489,151
-0.8%
52,050
+5.3%
0.54%
+0.7%
BuyGE HealthCare Technologies Inc$613,925
+99.2%
9,023
+137.9%
0.22%
+102.7%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-10-26
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Microsoft Corp42Q3 20235.3%
Merck & Co Inc42Q3 20233.2%
Pfizer Inc42Q3 20232.8%
Amgen Inc42Q3 20232.9%
Intel Corp42Q3 20233.1%
Bristol Myers Squibb Co42Q3 20232.9%
Paychex Inc42Q3 20232.3%
Lilly Eli Co42Q3 20234.4%
Verizon Communications42Q3 20232.6%
Johnson & Johnson42Q3 20232.2%

View Argyle Capital Management Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-29
13F-HR2024-02-05
13F-HR2023-10-26
13F-HR2023-07-27
13F-HR2023-04-27
13F-HR2023-02-06
13F-HR2022-10-21
13F-HR2022-07-20
13F-HR2022-04-27
13F-HR2022-01-25

View Argyle Capital Management Inc.'s complete filings history.

Compare quarters

Export Argyle Capital Management Inc.'s holdings